BeiGene, Ltd. (BGNE)
BeiGene, Ltd. Revenue
| Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.1M | $13.0M | $8,816.0K | $1,070.0K | $238.4M | $198.2M | $428.2M | $308.9M | $1,176.3M | $1,415.9M | $2,458.8M |
BeiGene, Ltd. (BGNE) Revenue comparison analysis
BGNE key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
FAQ
1) What is BeiGene, Ltd.'s Revenue?
As of today, BeiGene, Ltd.'s last 12-month Revenue is $3,316.8M, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is BeiGene, Ltd.'s Revenue growth rate?
Over the last year, BeiGene, Ltd.'s Revenue growth was 50.5%. The average annual Revenue growth rates for BeiGene, Ltd. have been 56.7% over the past three years, 50.5% over the past five years.
3) Is BeiGene, Ltd.'s Revenue growth rate Good?
Over the last year, BeiGene, Ltd.'s Revenue growth was 50.5%, which is higher than industry growth of 2.7%. It indicates that BeiGene, Ltd.'s Revenue growth is Good.